174 related articles for article (PubMed ID: 8545476)
1. Comparison of the antiemetic effects of a 5-HT1A agonist, LY228729, and 5-HT3 antagonists in the pigeon.
Wolff MC; Leander JD
Pharmacol Biochem Behav; 1995 Nov; 52(3):571-5. PubMed ID: 8545476
[TBL] [Abstract][Full Text] [Related]
2. Antiemetic effects of 5-HT1A agonists in the pigeon.
Wolff MC; Leander JD
Pharmacol Biochem Behav; 1994 Oct; 49(2):385-91. PubMed ID: 7824554
[TBL] [Abstract][Full Text] [Related]
3. Effects of a 5-HT1A receptor agonist on acute and delayed cyclophosphamide-induced vomiting.
Wolff MC; Leander JD
Eur J Pharmacol; 1997 Dec; 340(2-3):217-20. PubMed ID: 9537818
[TBL] [Abstract][Full Text] [Related]
4. The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon.
Preziosi P; D'Amato M; Del Carmine R; Martire M; Pozzoli G; Navarra P
Eur J Pharmacol; 1992 Oct; 221(2-3):343-50. PubMed ID: 1426010
[TBL] [Abstract][Full Text] [Related]
5. A dual effect of some 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon.
Navarra P; Martire M; del Carmine R; Pozzoli G; Preziosi P
Toxicol Lett; 1992 Dec; 64-65 Spec No():745-9. PubMed ID: 1471230
[TBL] [Abstract][Full Text] [Related]
6. Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy volunteers.
Cooper M; Sologuren A; Valiente R; Smith J
Arzneimittelforschung; 2002; 52(9):689-94. PubMed ID: 12404884
[TBL] [Abstract][Full Text] [Related]
7. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis.
Darmani NA
J Neural Transm (Vienna); 1998; 105(10-12):1143-54. PubMed ID: 9928884
[TBL] [Abstract][Full Text] [Related]
8. Volunteer models for predicting antiemetic activity of 5-HT3-receptor antagonists.
Minton NA
Br J Clin Pharmacol; 1994 Jun; 37(6):525-30. PubMed ID: 7917768
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus.
Horikoshi K; Yokoyama T; Kishibayashi N; Ohmori K; Ishii A; Karasawa A
Jpn J Pharmacol; 2001 Jan; 85(1):70-4. PubMed ID: 11243577
[TBL] [Abstract][Full Text] [Related]
10. The 5-HT3 agent N-(3-chlorophenyl)guanidine (MD-354) serves as a discriminative stimulus in rats and displays partial agonist character in a shrew emesis assay.
Dukat M; Young R; Darmani NN; Ahmed B; Glennon RA
Psychopharmacology (Berl); 2000 Jun; 150(2):200-7. PubMed ID: 10907673
[TBL] [Abstract][Full Text] [Related]
11. The anti-emetic activity of GK-128 in Suncus murinus.
Ito C; Isobe Y; Kijima H; Kiuchi Y; Ohtsuki H; Kawamura R; Tsuchida K; Higuchi S
Eur J Pharmacol; 1995 Oct; 285(1):37-43. PubMed ID: 8846809
[TBL] [Abstract][Full Text] [Related]
12. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva).
Darmani NA; Chebolu S; Amos B; Alkam T
Pharmacol Biochem Behav; 2011 Oct; 99(4):573-9. PubMed ID: 21683089
[TBL] [Abstract][Full Text] [Related]
14. Antiemetic effects of serotonergic 5-HT1A-receptor agonists in Suncus murinus.
Okada F; Torii Y; Saito H; Matsuki N
Jpn J Pharmacol; 1994 Feb; 64(2):109-14. PubMed ID: 8028227
[TBL] [Abstract][Full Text] [Related]
15. Preclinical studies on LY228729: a potent and selective serotonin1A agonist.
Foreman MM; Fuller RW; Leander JD; Benvenga MJ; Wong DT; Nelson DL; Calligaro DO; Swanson SP; Lucot JB; Flaugh ME
J Pharmacol Exp Ther; 1993 Oct; 267(1):58-71. PubMed ID: 8229788
[TBL] [Abstract][Full Text] [Related]
16. Involvement of 5-HT1A and 5-HT2 receptor in cisplatin induced emesis in dogs.
Gupta YK; Sharma SS
Indian J Physiol Pharmacol; 2002 Oct; 46(4):463-7. PubMed ID: 12683222
[TBL] [Abstract][Full Text] [Related]
17. Selective blockade of cytotoxic drug-induced emesis by 5-HT3 receptor antagonists in Suncus murinus.
Torii Y; Saito H; Matsuki N
Jpn J Pharmacol; 1991 Jan; 55(1):107-13. PubMed ID: 2041220
[TBL] [Abstract][Full Text] [Related]
18. Studies for the emetic mechanisms of ipecac syrup (TJN-119) and its active components in ferrets: involvement of 5-hydroxytryptamine receptors.
Hasegawa M; Sasaki T; Sadakane K; Tabuchi M; Takeda Y; Kimura M; Fujii Y
Jpn J Pharmacol; 2002 Jun; 89(2):113-9. PubMed ID: 12120752
[TBL] [Abstract][Full Text] [Related]
19. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
Yoshikawa T; Yoshida N; Oka M
Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms by which cancer chemotherapeutic drugs induce emesis.
Cubeddu LX
Semin Oncol; 1992 Dec; 19(6 Suppl 15):2-13. PubMed ID: 1485177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
